Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Roche Bioscience-Signal drug discovery collaboration

Sep. 27, 1996

SNX-111 development re-scheduled

Sep. 27, 1996

Sanofi reports tachykinin antagonists

Sep. 27, 1996

Glutamate inhibitor progresses through the pipeline

Sep. 20, 1996

Another series of mGluR antagonists from Lilly

Sep. 20, 1996

Metabotropic glutamate receptor antagonists from Lilly

Sep. 20, 1996

Metabotropic glutamate antagonists from Novo Nordisk

Sep. 20, 1996

Forest prepares submission for Alzheimer's disease product

Sep. 20, 1996

Bayer patents new compounds for CNS disorders

Sep. 20, 1996

Antiemetic 5-HT3 antagonist launched in Japan

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...